Printer Friendly

SEARLE PROVIDES 500,000 UNITS OF MEDICINES FOR SOMALIA IN RELIEF EFFORT SPEARHEADED BY U.S. SEN. SIMON

 CHICAGO, Jan. 7 /PRNewswire/ -- Sheldon G. Gilgore, M.D., chairman and chief executive officer of Searle, today announced the company has provided more than 500,000 units of antibiotics and other medicines for Somalian relief in response to an appeal by U.S. Sen. Paul Simon (D-Ill.).
 "Searle is pleased to answer Sen. Simon's call for assistance to the people of Somalia," according to Richard U. DeSchutter, Searle president, who has coordinated the Searle response. "Searle will provide antibiotics, including Maxaquin(R), and other products.
 "We expect transport of the medicines to get under way immediately," DeSchutter said. "Searle will work closely with international humanitarian organizations who are already at work staffing hospitals and providing medical care in Somalia."
 Simon contacted Searle and other Illinois corporations and organizations when U.S. troops were committed to Somalia in December, assuring safe passage for food and medicine in this East African nation torn by famine, drought and civil war. Simon chairs the subcommittee on African Affairs of the Senate Foreign Relations Committee and has led U.S. Senate efforts to provide relief in Somalia.
 Searle is a developer, manufacturer and marketer of prescription pharmaceuticals worldwide. It is a wholly owned subsidiary of Monsanto Company (NYSE: MTC).
 -0- 1/7/93
 /CONTACT: Kay Bruno of Searle, 708-470-6781; or David Carle of Sen. Simon's office, 202-224-7115/
 (MTC)


CO: Searle; Monsanto Company ST: Illinois IN: MTC SU:

CK -- NY070 -- 2689 01/07/93 12:55 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 7, 1993
Words:241
Previous Article:CREDIT SUISSE SUPPORTED STRUCT. TRANSACTIONS ON FITCHALERT -- FITCH FINANCIAL WIRE --
Next Article:INTEGRATED LABS ISSUES ANNOUNCEMENT
Topics:


Related Articles
SEARLE DONATES ANTI-INFECTIVE AGENT TO AID VICTIMS OF CHERNOBYL DISASTER
The final chapter: C-141 approaches historical conclusion as last flight nears.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters